| John Yingling, DO | |
|
825 Ne 10th St Ste 1c, Oklahoma City, OK 73104-5417 | |
| (405) 271-2663 | |
| (405) 271-3074 |
| Full Name | John Yingling |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 9 Years |
| Location | 825 Ne 10th St Ste 1c, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164800058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 7244 (Oklahoma) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ou Health Partners Inc | 5991105876 | 779 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
African-American women who get breast cancer often get more aggressive forms of the disease and at younger ages than other women.
Women with type 2 diabetes and heart disease have poorer control of both diseases and receive less intensive medical treatment than do men, a large new study found. The results have been presented Sunday, June 15, at The Endocrine Society's 90th Annual Meeting in San Francisco.
Conformetrix Ltd, a leader in optimising drug discovery and design, and AstraZeneca announced today that they have signed a research collaboration agreement under which Conformetrix's proprietary NMR-based technology will be applied across AstraZeneca's pre-clinical therapeutic pipeline to enhance lead discovery and hit identification.
Thermo Fisher Scientific Inc., the world leader in serving science, today debuted several innovations in bioprocessing technologies and systems that address the evolving requirements of drug discovery and production for global biopharmaceutical and pharmaceutical manufacturers.
› Verified 3 days ago
| Entity Name | Ou Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
African-American women who get breast cancer often get more aggressive forms of the disease and at younger ages than other women.
Women with type 2 diabetes and heart disease have poorer control of both diseases and receive less intensive medical treatment than do men, a large new study found. The results have been presented Sunday, June 15, at The Endocrine Society's 90th Annual Meeting in San Francisco.
Conformetrix Ltd, a leader in optimising drug discovery and design, and AstraZeneca announced today that they have signed a research collaboration agreement under which Conformetrix's proprietary NMR-based technology will be applied across AstraZeneca's pre-clinical therapeutic pipeline to enhance lead discovery and hit identification.
Thermo Fisher Scientific Inc., the world leader in serving science, today debuted several innovations in bioprocessing technologies and systems that address the evolving requirements of drug discovery and production for global biopharmaceutical and pharmaceutical manufacturers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Yingling, DO 825 Ne 10th St Ste 1c, Oklahoma City, OK 73104-5417 Ph: (405) 271-2663 | John Yingling, DO 825 Ne 10th St Ste 1c, Oklahoma City, OK 73104-5417 Ph: (405) 271-2663 |
News Archive
African-American women who get breast cancer often get more aggressive forms of the disease and at younger ages than other women.
Women with type 2 diabetes and heart disease have poorer control of both diseases and receive less intensive medical treatment than do men, a large new study found. The results have been presented Sunday, June 15, at The Endocrine Society's 90th Annual Meeting in San Francisco.
Conformetrix Ltd, a leader in optimising drug discovery and design, and AstraZeneca announced today that they have signed a research collaboration agreement under which Conformetrix's proprietary NMR-based technology will be applied across AstraZeneca's pre-clinical therapeutic pipeline to enhance lead discovery and hit identification.
Thermo Fisher Scientific Inc., the world leader in serving science, today debuted several innovations in bioprocessing technologies and systems that address the evolving requirements of drug discovery and production for global biopharmaceutical and pharmaceutical manufacturers.
› Verified 3 days ago
Dr. Kimberly S Smith, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-749-5025 Fax: 405-749-3585 | |
Mr. Nathan E Bradley, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3301 N.w. 50th St, Oklahoma City, OK 73112 Phone: 405-947-0911 | |
Thomas Craddock Howard Iii, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 9600 Broadway Ext, Oklahoma City, OK 73114 Phone: 405-230-9412 Fax: 405-230-9157 | |
Richard J Langerman Jr., DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 S Walker Ave Bldg A, Oklahoma City, OK 73139 Phone: 405-632-4468 Fax: 405-632-0436 | |
Dr. Rishi Thakral, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 825 Ne 10th St, Oupb 1c, Oklahoma City, OK 73104 Phone: 405-271-2663 Fax: 405-271-6762 | |
Dr. William Austin Doss, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5401 N Portland Ave # 600, Oklahoma City, OK 73112 Phone: 405-713-9941 | |
Paul Alan Kammerlocher, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3115 Sw 89th St, Oklahoma City, OK 73159 Phone: 405-486-6900 Fax: 405-486-6839 |